Your browser doesn't support javascript.
loading
Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessus.
Aragaw, Wassihun Wedajo; Negatu, Dereje A; Bungard, Christopher J; Dartois, Véronique A; Marrouni, Abdellatif El; Nickbarg, Elliott B; Olsen, David B; Warrass, Ralf; Dick, Thomas.
  • Aragaw WW; Center for Discovery and Innovation, Hackensack Meridian Health , Nutley, New Jersey, USA.
  • Negatu DA; Center for Discovery and Innovation, Hackensack Meridian Health , Nutley, New Jersey, USA.
  • Bungard CJ; Merck & Co., Inc. , West Point, Pennsylvania, USA.
  • Dartois VA; Center for Discovery and Innovation, Hackensack Meridian Health , Nutley, New Jersey, USA.
  • Marrouni AE; Department of Medical Sciences, Hackensack Meridian School of Medicine , Nutley, New Jersey, USA.
  • Nickbarg EB; Merck & Co., Inc. , West Point, Pennsylvania, USA.
  • Olsen DB; Merck & Co., Inc. , Boston, Massachusetts, USA.
  • Warrass R; Merck & Co., Inc. , West Point, Pennsylvania, USA.
  • Dick T; MSD Animal Health Innovation GmbH, Zur Propstei , Schwabenheim, Germany.
Antimicrob Agents Chemother ; 68(1): e0071723, 2024 Jan 10.
Article en En | MEDLINE | ID: mdl-38018963
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antagonistas del Ácido Fólico / Mycobacterium abscessus / Infecciones por Mycobacterium no Tuberculosas / Mycobacterium tuberculosis Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antagonistas del Ácido Fólico / Mycobacterium abscessus / Infecciones por Mycobacterium no Tuberculosas / Mycobacterium tuberculosis Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article